Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04998604 |
|---|---|
| Brief Title: | EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST) |
| First Submitted : | August 9, 2021 |
| First Submitted that Met QC Criteria : | August 9, 2021 |
| First Posted : | August 10, 2021 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |